Eugene W. Gerner is a professor of cell biology and anatomy and director of the gastrointestinal cancer program at the Arizona Cancer Center. An expert in the science of gastrointestinal cancer processes, his current research focuses on risk factors for gastrointestinal cancers and chemoprevention of epithelial cancers. He also is the founder of Cancer Prevention Pharmaceuticals, a Tucson-based biotechnology company working to develop FDA-approved indications for cancer prevention.
The sixth annual Innovation Day on March 26, 2009, celebrated The University of Arizona's success in technology development and innovation by showcasing the research achievements of students, staff and faculty, especially those who have successfully translated original and innovative technology ideas from the laboratory to the marketplace or are on track to do so. Among those recognized during the daylong celebration were five "Leading Edge Researchers," honored at a morning awards ceremony in the Student Union Memorial Center's Gallagher Theater.
All Comments